S4 E1 - Zachariah DeFilipp, MD – Emerging Treatment Paradigms in Myelodysplastic Syndromes

This is the first episode in our series on myelodysplastic syndromes which aims to update clinicians on the latest developments in their diagnosis and management.

In this episode, Dr. DeFilipp outlines the current and upcoming treatments for myelodysplastic syndromes. He discusses doublet and triplet combinations that are moving the needle on disease management, including emerging therapies and combinations of hypomethylating agents. He also considers which underlying mutations pose the greatest challenges and/or provide the greatest opportunities for future research in the field.

For more podcast episodes from Karger please visit karger.com/podcasts.

This podcast was funded by Taiho Oncology, Inc. The faculty and publisher are solely responsible for this content. Taiho does not recommend or endorse the use of its products other than as described in the approved labeling. The content of this site is not medical advice and does not replace independent medical judgment.